Highly potent modulation of GABA(A) receptors by valerenic acid derivatives.
Swiss Federal Institute of Technology, Zürich, Switzerland.
Sascha
S
Kopp
Roland
R
Baur
Erwin
E
Sigel
Hanns
H
Möhler
Karl-Heinz
KH
Altmann
D000818:Animals; D007192:Indenes / Q000138:chemical synthesis / Q000737:chemistry* / Q000494:pharmacology; D018377:Neurotransmitter Agents / Q000138:chemical synthesis / Q000737:chemistry* / Q000494:pharmacology; D009865:Oocytes / Q000378:metabolism; D011963:Receptors, GABA-A / Q000235:genetics / Q000378:metabolism*; D011994:Recombinant Proteins / Q000235:genetics / Q000378:metabolism; D012717:Sesquiterpenes / Q000138:chemical synthesis / Q000737:chemistry* / Q000494:pharmacology; D013777:Tetrazoles / Q000138:chemical synthesis / Q000737:chemistry* / Q000494:pharmacology; D014981:Xenopus
D007192:Indenes; D018377:Neurotransmitter Agents; D011963:Receptors, GABA-A; D011994:Recombinant Proteins; D012717:Sesquiterpenes; D013777:Tetrazoles; C045574:1H-tetrazole; C037133:valerenic acid